Clinical diagnostic biomarker “circulating tumor cells” in breast cancer - a meta-analysis

Clinical diagnostic biomarker “circulating tumor cells” in breast cancer - a meta-analysis

ObjectiveUsing meta-analysis, we evaluate circulating tumor cells(CTCs) as a potential diagnostic tool for breast cancer.MethodsA document search was conducted using publicly available databases up to May 2021. Specific inclusion and exclusion criteria were formulated and summarize relevant data thr...

Full description

Bibliographic Details
Main Authors:	Shiyan Bai, Shujin Lin, Ting Lin, Qiaowen Wang, Cui Cheng, Junru Lin, Ying Zhang, Xiwen Jiang, Xiao Han
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Oncology
Subjects:	circulating tumor cells breast cancer diagnostic meta-analysis liquid biopsy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1137519/full

Similar Items

Circulating miRNAs as biomarkers for the diagnosis in patients with melanoma: systematic review and meta-analysis
by: Nicholas Jones, et al.
Published: (2024-02-01)

Meta-analysis of diagnostic cell-free circulating microRNAs for breast cancer detection
by: Emir Sehovic, et al.
Published: (2022-06-01)

Exosomal microRNAs as novel diagnostic biomarkers in breast cancer: A systematic evaluation and meta-analysis
by: Fangcheng Hong, et al.
Published: (2023-11-01)

Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis
by: Dandan Yu, et al.
Published: (2019-03-01)

Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue
by: Tania Rossi, et al.
Published: (2021-09-01)

Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis
by: Nan Wu, et al.
Published: (2023-05-01)

The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer
by: Mira Shoukry, et al.
Published: (2021-07-01)

Circulating tumor cells in peripheral blood as a diagnostic biomarker of breast cancer: A meta-analysis
by: Tao Jin, et al.
Published: (2023-03-01)

A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer
by: Maha M. Itani, et al.
Published: (2021-06-01)

Study on circulating tumor DNA and circulating tumor cell detecting minimal residual disease in breast cancer
by: PAN Ruixin, CHEN Xiaosong, SHEN Kunwei
Published: (2022-09-01)

Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies
by: Marta Tellez-Gabriel, et al.
Published: (2020-12-01)

First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof‐of‐concept study
by: Thomas Bardol, et al.
Published: (2024-01-01)

Liquid-based biomarkers in breast cancer: looking beyond the blood
by: You Shuai, et al.
Published: (2023-11-01)

Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity
by: Claudia Koch, et al.
Published: (2020-09-01)

Circulating Tumor Cells in Metastatic Breast Cancer: Clinical Applications and Future Possibilities
by: Maggie Banys-Paluchowski, et al.
Published: (2020-05-01)

Detection of circulating tumour cells in the breast cancer using CytoTrack system
by: Bogacz Anna, et al.
Published: (2019-12-01)

Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer
by: Ilenia Migliaccio, et al.
Published: (2021-05-01)

The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis
by: Theresa D. Ahrens, et al.
Published: (2020-08-01)

Addressing the Clinical Feasibility of Adopting Circulating miRNA for Breast Cancer Detection, Monitoring and Management with Artificial Intelligence and Machine Learning Platforms
by: Lloyd Ling, et al.
Published: (2022-12-01)

Potential of circulating tumour DNA as a biomarker in liquid biopsy
by: Dimitar Dimitrov, et al.
Published: (2023-11-01)

Tumor‐proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells
by: Etienne Buscail, et al.
Published: (2019-09-01)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
by: Jie Li, et al.
Published: (2018-09-01)

Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy
by: Ying Zhou, et al.
Published: (2022-04-01)

Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial
by: Elisabeth K. Trapp, et al.
Published: (2022-08-01)

Candidate circulating microRNA biomarkers in dogs with chronic pancreatitis
by: Susan K. Armstrong, et al.
Published: (2024-03-01)

Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers
by: Sridevi Addanki, et al.
Published: (2022-07-01)

Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC
by: Yilin Li, et al.
Published: (2023-08-01)

A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients
by: Elisabeth M. Jongbloed, et al.
Published: (2021-04-01)

Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
by: Giulia Brisotto, et al.
Published: (2020-04-01)

The Diagnostic and Prognostic Value of a Liquid Biopsy for Esophageal Cancer: A Systematic Review and Meta-Analysis
by: Daisuke Matsushita, et al.
Published: (2020-10-01)

An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide
by: Michele Bevere, et al.
Published: (2023-08-01)

Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine
by: Maria Panagopoulou, et al.
Published: (2021-02-01)

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study
by: Eleni Tzanikou, et al.
Published: (2019-12-01)

DNA repair deficiency as circulating biomarker in prostate cancer
by: Martina Catalano, et al.
Published: (2023-01-01)

Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients
by: Yoshiaki Shoji, et al.
Published: (2022-02-01)

CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome
by: Ashvathi Raghavakaimal, et al.
Published: (2022-05-01)

The double agents in liquid biopsy: promoter and informant biomarkers of early metastases in breast cancer
by: Vinitha Richard, et al.
Published: (2022-04-01)

Editorial: Role of RNA in Molecular Diagnostics of Cancer
by: William C. S. Cho, et al.
Published: (2020-05-01)

Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer
by: Carolina Reduzzi, et al.
Published: (2021-05-01)

The contribution of the 20th century discoveries on the circulating DNA as biomarkers for cancer screening
by: GILDA ALVES, et al.
Published: (2020-11-01)